BioStem (BSEM) CAO Michael A. Fortunato Exercises 970 Options

What Happened

• Michael A. Fortunato, Chief Accounting Officer of BioStem Technologies (BSEM), reported an exercise/conversion of derivative securities on 2026-08-09. The filing shows an acquisition of 970 shares and a simultaneous disposition of 970 shares, both at a reported price of $0.00 (transaction code M = exercise or conversion of derivative). The filing reports no cash consideration or dollar value for these entries.

Key Details

• Transaction date: 2026-08-09 (reported on Form 4 filed 2026-08-20).
• Transaction type/code: M — exercise or conversion of derivative; acquisition 970 shares @ $0.00 and disposition 970 shares @ $0.00.
• Reported consideration/value: $0.00 for both acquisition and disposition entries (no cash value reported).
• Shares owned after the transaction: Not specified in the provided filing extract.
• Relevant filing notes: multiple vesting/RSU footnotes are included in the filing (see F1–F9). Footnote F6 explains that each restricted stock unit represents a contingent right to one share; footnote F8 notes an administrative error caused a delay in prior RSU reporting.
• Timeliness: The Form 4 was filed 11 days after the transaction (Aug 20 for an Aug 9 transaction), outside the two-business-day window — the filing was late.

Context

• Code M transactions mean options or other derivatives were exercised or converted into underlying shares. This filing shows both the exercise/conversion and an immediate disposition of the same number of shares; the $0.00 reported consideration means the Form 4 does not show cash proceeds or the method of settlement (e.g., cashless exercise, net-share settlement, or conversion of RSUs). The filing also includes Exhibit 24 (Power of Attorney).